Markets
markets
Luke Kawa
4/3/25

Wall Street’s new strategy: Hope that these tariffs aren’t real

The scale of the trade barriers announced by President Donald Trump on Wednesday means that any bull calls you see out of Wall Street today will have one tenet at their core: take Trump’s reciprocal tariffs seriously, but not literally.

Here’s Wedbush tech analyst Dan Ives:

“Over the coming 24 hours the world will quickly realize these tariff rates will never stay as they are shown otherwise it would be a self-inflicted Economic Armageddon that Trump would send the US and world through over the coming year. We have to assume this is the start of a negotiation and these rates will not hold... stocks will sell-off massively but ultimately our view is these numbers would throw the US into a clear recession and cause stagflation almost immediately... IF they hold (and they will not for long, in our view).

For today with clients... we are taking the approach after speaking with business leaders/supply chain experts from around the world last night that these tariffs (and the fascinating calculations which need to be explained by someone from the White House today) are the start of negotiations with countries and even individual companies to even the playing field. If you start with that assumption then the massive sell-off today (and potentially over the coming days) is a major buying opportunity to own the best tech winners on sale for a policy that will be temporary and not permanent.”

Ives adds that “our focus to own this morning” is Wedbush’s tech winners basket, which includes Nvidia, Microsoft, Amazon, Apple, Tesla, Palantir, Alphabet, Palo Alto Networks, CyberArk, and Check Point Software.

We’ve been pretty vocal about the idea that the proximate cause of the stock market’s retreat from all-time highs has been more a momentum unwind than a pricing in of the economic downside risks that loom following the imposition of tariffs. That’s in part because investors with some memory of Trump 1.0 policy sequencing, as well as the stock market serving as a “report card” for that administration, had cause to shrug off fiery trade rhetoric as cases of the president’s bark being worse than his bite.

Trump Hot Air Cycle
Source: Sherwood News

When we first wrote about the “Trump Hot Air Cycle,” we noted that this method of thinking conditions investors to react late to negative catalysts — that this is a miniature version of Hyman Minsky’s “stability breeds instability” argument.

“What’s needed to break this cycle? Well, action that everyone was warned about but no one thought was coming, probably,” was the thought. Action that everybody was warned about but no one thought was coming sounds an awful lot like a scheduled “Liberation Day” Rose Garden address. And based on the reaction we’re seeing today in markets — which comes amid a continued reluctance to countenance the outcome of these measures as a new, enduring reality — yes, this has the potential to be a paradigm-shattering event.

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.